As a university student, Dalton Signor was troubled by how many people around him smoked or vaped, including his grandmother and 14-year-old sister.
Signor (pictured center) felt that existing smoking cessation medicines, whether patches, gums, or lozenges, are not very effective because they take too long to start working. “They take about 30 minutes to provide relief, but the average person relapses in 11 minutes,” he told TechCrunch.
So, three years ago, he set out to develop a withdrawal-inhibitor inhaler because delivering…
